title: In vitro immunogenicity of silicon-based micro- and nanostructured surfaces.
abstract: The increasing use of micro- and nanostructured silicon-based devices for in vivo therapeutic or sensing applications highlights the importance of understanding the immunogenicity of these surfaces. Four silicon surfaces (nanoporous, microstructured, nanochanneled, and flat) were studied for their ability to provoke an immune response in human blood derived monocytes. The monocytes were incubated with the surfaces for 48 h and the immunogenicity was evaluated based on the viability, shape factors, and cytokine expression. Free radical oxygen formation was measured at 18 h to elicit a possible mechanism invoking immunogenicity. Although no cytokines were significantly different comparing the response of monocytes on the tissue culture polystyrene surfaces to those on the micropeaked surfaces, on average all cytokines were elevated on the micropeaked surface. The monocytes on the nanoporous surface also displayed an elevated cytokine response, overall, but not to the degree of those on the micropeaked surface. The nanochanneled surface response was similar to that of flat silicon. Overall, the immunogenicity and biocompatibility of flat, nanochanneled, and nanoporous silicon toward human monocytes are approximately equivalent to tissue culture polystyrene.
authors.affiliation: Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California 94158, USA.
authors.forename: Kristy M
authors.initials: KM
authors.lastname: Ainslie
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Tao
authors.forename: Ketul C
authors.initials: KC
authors.lastname: Popat
authors.forename: Tejal A
authors.initials: TA
authors.lastname: Desai
mesh_terms: D002478:Cells, Cultured; D016207:Cytokines / Q000276:immunology*; D005609:Free Radicals / Q000276:immunology; D006801:Humans; D055261:Immunogenetic Phenomena / Q000187:drug effects / Q000276:immunology*; D008422:Materials Testing; D009000:Monocytes / Q000187:drug effects / Q000276:immunology*; D049329:Nanostructures / Q000008:administration & dosage*; D017382:Reactive Oxygen Species / Q000276:immunology*; D012825:Silicon / Q000008:administration & dosage*
chemical_list: D016207:Cytokines; D005609:Free Radicals; D017382:Reactive Oxygen Species; D012825:Silicon